These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 34929474)
41. Thalamus and focal to bilateral seizures: A multiscale cognitive imaging study. Caciagli L; Allen LA; He X; Trimmel K; Vos SB; Centeno M; Galovic M; Sidhu MK; Thompson PJ; Bassett DS; Winston GP; Duncan JS; Koepp MJ; Sperling MR Neurology; 2020 Oct; 95(17):e2427-e2441. PubMed ID: 32847951 [TBL] [Abstract][Full Text] [Related]
42. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe. Steinhoff BJ; Christensen J; Doherty CP; Majoie M; De Backer M; Hellot S; Leunikava I; Leach JP Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096 [TBL] [Abstract][Full Text] [Related]
43. Vigabatrin add-on therapy for drug-resistant focal epilepsy. Bresnahan R; Gianatsi M; Maguire MJ; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007302. PubMed ID: 32730657 [TBL] [Abstract][Full Text] [Related]
44. Potentially high-risk cardiac arrhythmias with focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures are associated with the duration of periictal hypoxemia. Park KJ; Sharma G; Kennedy JD; Seyal M Epilepsia; 2017 Dec; 58(12):2164-2171. PubMed ID: 29105057 [TBL] [Abstract][Full Text] [Related]
46. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Marson AG; Tudur Smith C Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037 [TBL] [Abstract][Full Text] [Related]
47. Terminal seizure frequency and its relation to SUDEP. Chen D; Si Y; He J; Deng Y; Chen T; He YJ; Liu L; Zhou D Epilepsy Behav; 2017 May; 70(Pt A):173-176. PubMed ID: 28427028 [TBL] [Abstract][Full Text] [Related]
48. Comparative 12-month retention rate, effectiveness and tolerability of perampanel when used as a first add-on or a late add-on treatment in patients with focal epilepsies: The COM-PER study. Canas N; Félix C; Silva V; Arraiolos A; Fernandez-Llimos F Seizure; 2021 Mar; 86():109-115. PubMed ID: 33592505 [TBL] [Abstract][Full Text] [Related]
49. Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. Nolan SJ; Marson AG; Pulman J; Tudur Smith C Cochrane Database Syst Rev; 2013 Aug; (8):CD001769. PubMed ID: 23970302 [TBL] [Abstract][Full Text] [Related]
50. Coffee Consumption and Risk of Atrial Fibrillation in the Physicians' Health Study. Bodar V; Chen J; Gaziano JM; Albert C; Djoussé L J Am Heart Assoc; 2019 Aug; 8(15):e011346. PubMed ID: 31378120 [TBL] [Abstract][Full Text] [Related]
51. Focal seizure symptoms in idiopathic generalized epilepsies. Seneviratne U; Woo JJ; Boston RC; Cook M; D'Souza W Neurology; 2015 Aug; 85(7):589-95. PubMed ID: 26187225 [TBL] [Abstract][Full Text] [Related]
52. The Significance of Interictal Spike Frequency in Temporal Lobe Epilepsy. Asadollahi M; Noorbakhsh M; Salehifar V; Simani L Clin EEG Neurosci; 2020 May; 51(3):180-184. PubMed ID: 31884820 [No Abstract] [Full Text] [Related]
53. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies. Piña-Garza JE; Rosenfeld W; Saeki K; Villanueva V; Yoshinaga H; Patten A; Williams B; Malhotra M Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998 [TBL] [Abstract][Full Text] [Related]
54. Genetic generalized and focal epilepsy prevalence in the North American SUDEP Registry. Verducci C; Friedman D; Donner E; Devinsky O Neurology; 2020 Apr; 94(16):e1757-e1763. PubMed ID: 32217773 [TBL] [Abstract][Full Text] [Related]
55. An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies. Manford M; Fish DR; Shorvon SD Brain; 1996 Feb; 119 ( Pt 1)():17-40. PubMed ID: 8624679 [TBL] [Abstract][Full Text] [Related]
56. Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery. Elsharkawy AE; Thorbecke R; Ebner A; May TW Epilepsy Behav; 2012 Jun; 24(2):249-55. PubMed ID: 22534356 [TBL] [Abstract][Full Text] [Related]
57. Increasing the dosage of pregabalin in patients with focal epilepsy decreases the frequency of seizures and ameliorates symptoms of anxiety, depression and insomnia. Murawiec S; Chudek J; Nieves W; Almgren-Rachtan A; Jedrzejczak J Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13015-13024. PubMed ID: 33378053 [TBL] [Abstract][Full Text] [Related]
58. Tonic-clonic seizures in idiopathic generalized epilepsies: Prevalence, risk factors, and outcome. Asadi-Pooya AA; Homayoun M Acta Neurol Scand; 2020 Jun; 141(6):445-449. PubMed ID: 32030724 [TBL] [Abstract][Full Text] [Related]
59. Rufinamide add-on therapy for drug-resistant epilepsy. Panebianco M; Prabhakar H; Marson AG Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247 [TBL] [Abstract][Full Text] [Related]